Outlook Therapeutics raises $5M at $0.31/share, reprices old warrants 86% lower to $0.31

Filed April 23, 2026 · Period ending April 22, 2026 · ~1 min read

Key Changes

• high

  Sold 16.1M shares at $0.31 with matching warrants, raising ~$5M gross; warrants exercisable only after shareholder approval of share issuance and authorized share increase (meeting within 90 days).

  Item 8.01 verify on EDGAR →
• high

  Repriced 2.1M existing warrants from $2.26 to $0.31 (86% reduction) for a participating investor, making previously out-of-the-money warrants immediately in-the-money at the offering price.

  Item 8.01 verify on EDGAR →
• high

  Full warrant exercise would add 16.1M shares (roughly doubling dilution from this round); warrants expire five years after effectiveness and shareholder approval.

  Item 8.01 verify on EDGAR →